AXM Pharma, Inc.
AXMP
$0.0001
$0.000.00%
OTC PK
| 06/30/2018 | 03/31/2018 | ||||
|---|---|---|---|---|---|
| Revenue | -3.72% | -3.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.72% | -3.72% | |||
| Cost of Revenue | -5.54% | -5.54% | |||
| Gross Profit | 7.99% | 7.99% | |||
| SG&A Expenses | -- | -- | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -53.65% | -53.65% | |||
| Total Operating Expenses | -1.33% | -1.33% | |||
| Operating Income | -21.32% | -21.32% | |||
| Income Before Tax | -6.03% | -6.03% | |||
| Income Tax Expenses | -35.48% | -35.48% | |||
| Earnings from Continuing Operations | 4.52% | 4.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.52% | 4.52% | |||
| EBIT | -21.32% | -21.32% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | -- | -- | |||
| Average Diluted Shares Outstanding | -- | -- | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||